Published in Gut on June 01, 1996
Oxidative stress: an essential factor in the pathogenesis of gastrointestinal mucosal diseases. Physiol Rev (2014) 1.57
Clinical and histological associations of cagA and vacA genotypes in Helicobacter pylori gastritis. J Clin Pathol (1998) 1.17
Epithelial intestinal cell apoptosis induced by Helicobacter pylori depends on expression of the cag pathogenicity island phenotype. Infect Immun (2001) 1.00
Emerging role of IL-23/IL-17 axis in H pylori-associated pathology. World J Gastroenterol (2007) 0.99
Gastric cancer, Helicobacter pylori infection and other risk factors. World J Gastrointest Oncol (2010) 0.96
Potent antiulcerogenic activity of ethanol extract of leaf ofPiper betle Linn by antioxidative mechanism. Indian J Clin Biochem (2002) 0.90
Helicobacter pylori eradication ameliorates primary Raynaud's phenomenon. Dig Dis Sci (1998) 0.79
The Origins of Gastric Cancer From Gastric Stem Cells: Lessons From Mouse Models. Cell Mol Gastroenterol Hepatol (2017) 0.78
Relationship between mucosal levels of interleukin 8 and toxinogenicity of Helicobacter pylori. Inflammopharmacology (1998) 0.78
Tissue destruction by neutrophils. N Engl J Med (1989) 13.81
Cytotoxic activity in broth-culture filtrates of Campylobacter pylori. J Med Microbiol (1988) 8.69
Mucosal IgA recognition of Helicobacter pylori 120 kDa protein, peptic ulceration, and gastric pathology. Lancet (1991) 6.73
Essential role of urease in pathogenesis of gastritis induced by Helicobacter pylori in gnotobiotic piglets. Infect Immun (1991) 5.90
Cytotoxin production by Campylobacter pylori strains isolated from patients with peptic ulcers and from patients with chronic gastritis only. J Clin Microbiol (1989) 4.86
Free radicals, antioxidants, and human disease: where are we now? J Lab Clin Med (1992) 4.82
CagA/cytotoxic strains of Helicobacter pylori and interleukin-8 in gastric epithelial cell lines. J Clin Pathol (1994) 3.48
Soluble surface proteins from Helicobacter pylori activate monocytes/macrophages by lipopolysaccharide-independent mechanism. J Clin Invest (1991) 3.00
Expression of 120 kilodalton protein and cytotoxicity in Helicobacter pylori. J Clin Pathol (1992) 2.60
Helicobacter pylori stimulates antral mucosal reactive oxygen metabolite production in vivo. Gut (1994) 2.10
Characterization of a Helicobacter pylori neutrophil-activating protein. Infect Immun (1995) 1.97
Correlation between vacuolating cytotoxin production by Helicobacter pylori isolates in vitro and in vivo. Infect Immun (1993) 1.97
Neutrophil-mediated mucosal injury. Role of reactive oxygen metabolites. Dig Dis Sci (1988) 1.81
Intra- and extracellular events in luminol-dependent chemiluminescence of polymorphonuclear leukocytes. Infect Immun (1984) 1.77
Activation of human phagocyte oxidative metabolism by Helicobacter pylori. Gastroenterology (1992) 1.49
Mucosal reactive oxygen metabolite production in duodenal ulcer disease. Gut (1992) 1.36
Opsonophagocytosis of Campylobacter pylori. J Med Microbiol (1988) 1.13
Inflammatory bowel disease--a radical view. Gut (1993) 1.06
A radical view of the stomach: the role of oxygen-derived free radicals and anti-oxidants in gastroduodenal disease. Eur J Gastroenterol Hepatol (1995) 1.00
Opsonic requirements of Helicobacter pylori. J Med Microbiol (1993) 0.85
Inhibition of human gastric cyclic AMP production by Helicobacter pylori protein--possible involvement of mucosal prostaglandin E2. Aliment Pharmacol Ther (1991) 0.81
Randomised comparison of percutaneous endoscopic gastrostomy and nasogastric tube feeding in patients with persisting neurological dysphagia. BMJ (1992) 4.32
Gastrointestinal damage associated with the use of nonsteroidal antiinflammatory drugs. N Engl J Med (1992) 4.27
Peptic ulcer in rheumatoid arthritis. Ann Rheum Dis (1988) 2.46
Famotidine for the prevention of gastric and duodenal ulcers caused by nonsteroidal antiinflammatory drugs. N Engl J Med (1996) 2.37
Struggling toward easier endoscopy. Gastrointest Endosc (1998) 2.33
Toxic epidermal necrolysis produced by an extracellular product of Staphylococcus aureus. Br J Dermatol (1971) 2.23
Oro-facial granulomatosis--a clinical and pathological analysis. Q J Med (1985) 2.11
Antimicrobial susceptibility testing of Actinomyces species with 12 antimicrobial agents. J Antimicrob Chemother (2005) 1.86
Identification of coagulase-negative staphylococci with the API staph system. J Clin Microbiol (1982) 1.85
Potentiation of opsonization and phagocytosis of Streptococcus pyogenes following growth in the presence of clindamycin. J Clin Invest (1981) 1.82
Famotidine for healing and maintenance in nonsteroidal anti-inflammatory drug-associated gastroduodenal ulceration. Gastroenterology (1997) 1.59
A study of the role of bile acids in the pathogenesis of postvagotomy diarrhoea. Gut (1973) 1.58
Nonsteroidal peptic damage in rheumatoid patients receiving second-line drugs. Am J Gastroenterol (1991) 1.57
Antacid maintenance therapy in the prevention of duodenal ulcer relapse. Gut (1988) 1.54
Pathogenicity of Staphylococcus lugdunensis, Staphylococcus schleiferi, and three other coagulase-negative staphylococci in a mouse model and possible virulence factors. Can J Microbiol (1990) 1.51
Usefulness of mec-associated direct repeat unit (dru) typing in the epidemiological analysis of highly clonal methicillin-resistant Staphylococcus aureus in Scotland. Clin Microbiol Infect (2008) 1.50
Importance of cryptolytic lesions and pericryptal granulomas in inflammatory bowel disease. J Clin Pathol (1997) 1.45
Magnesium deficiency in patients on home enteral nutrition. Clin Nutr (1990) 1.39
Neodymium yttrium aluminium garnet laser photocoagulation for major haemorrhage from peptic ulcers and single vessels: a single blind controlled study. Br Med J (Clin Res Ed) (1983) 1.39
Characterization of Clostridium difficile and its differentiation from Clostridium sporogenes by automatic head-space gas chromatography. Scand J Infect Dis Suppl (1980) 1.34
Serological diagnosis of Helicobacter pylori--evaluation of four tests in the presence or absence of non-steroidal anti-inflammatory drugs. Gut (1993) 1.32
Collagenous colitis: possible response to sulfasalazine and local steroid therapy. Gastroenterology (1985) 1.30
Persistence of Staphylococcus aureus as detected by polymerase chain reaction in the synovial fluid of a patient with septic arthritis. Br J Rheumatol (1997) 1.24
Helicobacter pylori and non-steroidal anti-inflammatory drugs: uncomfortable partners in peptic ulcer disease. Gut (1993) 1.24
A comparison of computed tomography, ultrasound and scintigraphy in the diagnosis of alcoholic liver disease. Br J Radiol (1984) 1.21
Home enteral tube feeding with a liquid diet in the long term management of inflammatory bowel disease and intestinal failure. Scott Med J (1980) 1.20
Neutrophil bactericidal function in diabetes mellitus: evidence for association with blood glucose control. Diabet Med (1995) 1.18
Effect of staphylococcal alpha-toxin on phagocytosis of staphylococci by human polymorphonuclear leukocytes. Infect Immun (1982) 1.17
Raised titres of anti-klebsiella IgA in ankylosing spondylitis, rheumatoid arthritis, and inflammatory bowel disease. Br Med J (Clin Res Ed) (1988) 1.17
Helicobacter pylori and peptic ulcers in rheumatoid arthritis patients receiving gold, sulfasalazine, and nonsteroidal anti-inflammatory drugs. Am J Gastroenterol (1992) 1.16
Evidence for a role of hepatitis virus B in chronic alcoholic liver disease. Lancet (1972) 1.16
Impairment by Bacteroides species of opsonisation and phagocytosis of enterobacteria. J Med Microbiol (1982) 1.16
Chemical gastritis and Helicobacter pylori related gastritis in patients receiving non-steroidal anti-inflammatory drugs: comparison and correlation with peptic ulceration. J Clin Pathol (1992) 1.14
Biological effects of the interaction of staphylococcal alpha-toxin with human serum. Infect Immun (1982) 1.11
Alcohol and absorption from the small intestine. 1. Impairment of absorption from the small intestine in alcoholics. Gut (1976) 1.10
Elemental diet therapy in the management of complicated Crohn's disease. Scott Med J (1979) 1.10
Crohn's disease of the mouth: an indicator of intestinal involvement. Gut (1982) 1.08
Toxinogenicity of clinical isolates of coagulase-negative staphylococci towards various animal cells. Acta Pathol Microbiol Scand B (1981) 1.07
The pathogenesis of pneumococcal infection in mice. J Med Microbiol (1971) 1.06
Gastric mucosal prostaglandin synthesis in the presence of Campylobacter pylori in patients with gastric ulcers and non-ulcer dyspepsia. Am J Gastroenterol (1990) 1.06
Effect of prostaglandin 15(R) 15 methyl-E2 methyl ester on aspirin and taurocholic acid-induced gastric mucosal haemorrhage in rats. Gut (1976) 1.04
A combined TDDA-PVC pH and reference electrode for use in the upper small intestine. J Med Eng Technol (1990) 1.04
The effect of conjugated and unconjugated bile acids on water and electrolyte absorption in the human jejunum. Clin Sci Mol Med (1973) 1.04
Pre- and postweaning disaccharidase patterns in isografts of fetal mouse intestine. Gastroenterology (1973) 1.04
Role of bile acids in the pathogenesis of aspirin-induced gastric mucosal hemorrhage in rats. Gastroenterology (1975) 1.04
Intravenous feeding to sustain pregnancy in patient with Crohn's disease. Br Med J (Clin Res Ed) (1981) 1.02
Measurement of fat absorption using [3H]glycerol triether and [14C]glycerol trioleate in man. Clin Chim Acta (1980) 1.01
Functional and structural changes of the human proximal small intestine after cytotoxic therapy. J Clin Pathol (1985) 1.01
Hepatic granulomas: experience over a 10-year period in the West of Scotland. Q J Med (1982) 1.01
A study by perfusion techniques of the absorption abnormalities in the jejunum in adult coeliac disease. Clin Sci (1972) 1.01
Comparison of three adrenoreceptor blocking agents in patients with cirrhosis and portal hypertension. Gut (1984) 1.00
Campylobacter pylori associated gastritis in patients with rheumatoid arthritis taking nonsteroidal anti-inflammatory drugs. Br J Rheumatol (1988) 1.00
Increased intestinal permeability in ankylosing spondylitis--primary lesion or drug effect? Gut (1991) 0.99
The role of bile acids in the pathogenesis of postvagotomy diarrhoea. Br J Surg (1974) 0.99
Studies into the role of the SEF14 fimbrial antigen in the pathogenesis of Salmonella enteritidis. Microb Pathog (1996) 0.99
Outcome after severe non-accidental head injury. Arch Dis Child (1997) 0.99
Putative virulence factor expression by clinical and food isolates of Bacillus spp. after growth in reconstituted infant milk formulae. Appl Environ Microbiol (2001) 0.98
Duodenal histology, ulceration, and Helicobacter pylori in the presence or absence of non-steroidal anti-inflammatory drugs. Gut (1993) 0.98
Vocal cord paralysis and oesophago-broncho-aortic fistula complicating foreign body-induced oesophageal perforation. Postgrad Med J (1992) 0.98
Comparison of different measurements of intestinal permeability in inflammatory bowel disease. Am J Gastroenterol (1991) 0.97
Gastric and duodenal mucosal blood flow in patients receiving non-steroidal anti-inflammatory drugs--influence of age, smoking, ulceration and Helicobacter pylori. Aliment Pharmacol Ther (1993) 0.97
Helicobacter pylori: bridging the credibility gap. Gut (1990) 0.97
Toxins and enzymes of coagulase negative staphylococci isolated from human infections. J Hyg Epidemiol Microbiol Immunol (1974) 0.95
Effect on gastric and duodenal mucosal prostaglandins of repeated intake of therapeutic doses of naproxen and etodolac in rheumatoid arthritis. Ann Rheum Dis (1990) 0.95
Alcoholic liver disease in Scotland and northeastern England: presenting features in 510 patients. Q J Med (1983) 0.94
Haemolysin and enzyme patterns of coagulase-positive staphylococci isolated from toxic epidermal necrolysis, Ritter's disease and impetigo contagiosa. J Med Microbiol (1969) 0.93
Diagnosis of the abuse of magnesium and stimulant laxatives. Ann Clin Biochem (1991) 0.92
Regulation of protein A biosynthesis in Staphylococcus aureus by certain antibiotics: its effect on phagocytosis by leukocytes. J Antimicrob Chemother (1983) 0.92
Antibiotic-induced modification of Bacteroides fragilis and its susceptibility to phagocytosis by human polymorphonuclear leukocytes. Eur J Clin Microbiol (1983) 0.92
Mucosal erosions in longterm non-steroidal anti-inflammatory drug users: predisposition to ulceration and relation to Helicobacter pylori. Gut (1995) 0.92
Predicting NSAID related ulcers--assessment of clinical and pathological risk factors and importance of differences in NSAID. Gut (1994) 0.91
A comparison of different methods of assessing free radical activity in type 2 diabetes and peripheral vascular disease. Diabet Med (1993) 0.91
Gut mucosal protein synthesis measured using intravenous and intragastric delivery of stable tracer amino acids. Am J Physiol (1995) 0.91
Toxic shock syndrome and endocarditis. Br Med J (Clin Res Ed) (1983) 0.91
Enhanced bacterial phagocytosis by peripheral blood monocytes in rheumatoid arthritis. Ann Rheum Dis (1984) 0.91
Vitamin A deficiency in Crohn's disease. Gut (1983) 0.91
The measurement of gastric transmucosal potential difference through a gastroduodenoscope. Gut (1973) 0.91
Diagnostic tests for Helicobacter pylori: comparison and influence of non-steroidal anti-inflammatory drugs. J Clin Pathol (1992) 0.91
Small-intestinal changes induced by an elemental diet (Vivonex) in normal rats. Clin Sci Mol Med (1978) 0.91
Potentiation of phagocytosis of pathogenic bacteria by exposure to low concentrations of antibiotics. J Antimicrob Chemother (1984) 0.90
Origins of Staphylococcus epidermidis and Streptococcus oralis causing bacteraemia in a bone marrow transplant patient. J Med Microbiol (2000) 0.90
Measurement of jejunal surface pH in situ by plastic pH electrode in patients with coeliac disease. Scand J Gastroenterol (1987) 0.90
The incidence and clinical significance of faecal hydroxy fatty acids. Gut (1969) 0.90
Remote clinical assessment of gastrointestinal endoscopy (tele-endoscopy): an initial experience. Proc AMIA Symp (2000) 0.90
Management of NSAID induced gastrointestinal disturbance. Ann Rheum Dis (1987) 0.90
Comparison of the effect of aspirin and choline magnesium trisalicylate on thromboxane biosynthesis in human platelets: role of the acetyl moiety. Haemostasis (1989) 0.90
Nature and standards of gastrointestinal and liver services in the United Kingdom. Gut (1993) 0.90
The interaction between Helicobacter pylori culture filtrate and indomethacin: effects on the integrity of human gastric antral mucosa and its prostaglandin E2 production in vitro. Aliment Pharmacol Ther (1990) 0.89
Neutrophils, Helicobacter pylori, and nonsteroidal anti-inflammatory drug ulcers. Gastroenterology (1999) 0.89
Bacteriostatic activity of human lactoferrin against Staphylococcus aureus is a function of its iron-binding properties and is not influenced by antibiotic resistance. FEMS Immunol Med Microbiol (2001) 0.89
Effect of clindamycin, erythromycin, lincomycin, and tetracycline on growth and extracellular lipase production by propionibacteria in vitro. Antimicrob Agents Chemother (1982) 0.88
A prospective survey of radiological bone and joint changes in primary biliary cirrhosis. Clin Radiol (1981) 0.88
Comparative study of the nature and biological activities of bacterial enterotoxins. J Med Microbiol (1984) 0.88
Effect of four antibiotics on haemolysin production and adherence to human uroepithelial cells by Escherichia coli. J Med Microbiol (1983) 0.87
The effect of pH on folic acid absorption in man. Clin Sci Mol Med (1976) 0.87
Pathogenicity and virulence of coagulase negative staphylococci in relation to adherence, hydrophobicity, and toxin production in vitro. J Clin Pathol (1994) 0.87